Expression of proliferating cell nuclear antigen and bcl-2 during a pseudomenopausal state induced by presurgical treatment of uterine leiomyomas with gonadotropin-releasing hormone analogues plus tibolone.
De Falco
Marianna
M
Department of Obstetrical-Gynaecological and Urological Science and Reproductive Medicine, University Federico II of Naples, Napoli, Italy.
Staibano
Stefania
S
Pollio
Fabrizio
F
Salvatore
Gaetano
G
Pontillo
Massimo
M
Ciociola
Francesca
F
Mansueto
Gelsomina
G
Di Lieto
Andrea
A
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007889:Leiomyoma / Q000188:drug therapy* / Q000378:metabolism / Q000601:surgery; D016729:Leuprolide / Q000627:therapeutic use*; D009652:Norpregnenes / Q000627:therapeutic use*; D018809:Proliferating Cell Nuclear Antigen / Q000096:biosynthesis*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis*; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000601:surgery
D009652:Norpregnenes; D018809:Proliferating Cell Nuclear Antigen; D019253:Proto-Oncogene Proteins c-bcl-2; D016729:Leuprolide; C027385:tibolone